JPMorgan reports 4.47M Zura Bio holdings (NASDAQ: ZURA) — 4.7% stake

Rhea-AI Filing Summary

Zura Bio Ltd: JPMorgan Chase filed an amended Schedule 13G/A reporting beneficial ownership of 4,471,316 Class A Ordinary Shares, equal to 4.7% of the class as disclosed in Item 4.

The filing lists sole voting power and sole dispositive power over 4,471,316 shares and identifies J.P. Morgan Securities PLC and J.P. Morgan Securities LLC as relevant subsidiaries. The amendment is signed by a JPMorgan vice president.

Insights

Institutional Ownership Analyst

JPMorgan reports a sub-5% passive holding in Zura Bio, consistent with Schedule 13G treatment.

The amendment records beneficial ownership of 4,471,316 shares (4.7%) with sole voting and dispositive power in JPMorgan's control. The Schedule 13G/A form indicates passive or qualifying institutional ownership rather than an active Section 13(d) acquisition.

Cash-flow treatment and intent are not stated in the excerpt; subsequent filings could disclose changes if the holding crosses statutory thresholds or the firm's intent changes.

Key Figures

Beneficial ownership: 4,471,316 shares Percent of class: 4.7% Sole voting/dispositive power: 4,471,316 shares

3 metrics

Beneficial ownership 4,471,316 shares Item 4 ownership disclosure

Percent of class 4.7% Item 4 percent of class

Sole voting/dispositive power 4,471,316 shares Item 4(i) and 4(iii) sole power to vote and dispose

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power, J.P. Morgan Securities PLC

4 terms

Schedule 13G/A regulatory

"Item 1. (a) Name of issuer: Zura Bio Ltd"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Item 4. (a) Amount beneficially owned: 4,471,316"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Item 4. (iii) Sole power to dispose or to direct the disposition of: 4,471,316"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

J.P. Morgan Securities PLC other

"Item 7. J.P. Morgan Securities PLC; J.P. Morgan Securities LLC"

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Zura Bio Ltd

(Name of Issuer)

Class A Ordinary Shares, par value $0.0001 per share

(Title of Class of Securities)

G9TY5A101

(CUSIP Number)

04/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G9TY5A101

1

Names of Reporting Persons

JPMORGAN CHASE & CO

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,471,316.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,471,316.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,471,316.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.7 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Zura Bio Ltd
(b)	Address of issuer's principal executive offices: 1489 W. Warm Springs Rd. #110, Henderson, NEVADA, 89014
Item 2.
(a)	Name of person filing: JPMORGAN CHASE & CO
(b)	Address or principal business office or, if none, residence: 270 Park Avenue, New York, NY 10017
(c)	Citizenship: DE
(d)	Title of class of securities: Class A Ordinary Shares, par value $0.0001 per share
(e)	CUSIP No.: G9TY5A101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,471,316
(b)	Percent of class: 4.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,471,316
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 4,471,316
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. J.P. Morgan Securities PLC; J.P. Morgan Securities LLC
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

JPMORGAN CHASE & CO

Signature:	Rachel Tsvaygoft
Name/Title:	Vice President
Date:	05/06/2026

FAQ

What stake does JPMorgan report in ZURA?

JPMorgan reports beneficial ownership of 4,471,316 Class A shares representing 4.7% of the class. The Schedule 13G/A lists sole voting and dispositive power over those shares and cites J.P. Morgan Securities PLC and LLC as related subsidiaries.

Does the Schedule 13G/A indicate JPMorgan is an active acquirer of ZURA?

No. The filing is an amendment to a Schedule 13G/A, which typically reflects passive or qualifying institutional ownership rather than an active Section 13(d) acquisition. The form lists ownership and voting/dispositive powers without stating activist intent or acquisition plans.

Who within JPMorgan signed the ZURA amendment?

The amendment was signed by Rachel Tsvaygoft, Vice President. The signature block shows the form was executed on 05/06/2026, with the reported ownership amount tied to the filing's Item 4 disclosure.

Are any subsidiaries identified as holding the ZURA shares?

Yes. The filing names J.P. Morgan Securities PLC and J.P. Morgan Securities LLC as the subsidiaries associated with the reported beneficial ownership. The Schedule 13G/A includes subsidiary identification under the relevant Item.